Pharmeasy owned Thyrocare Technologies declared an interim dividend of ₹18 per share
Link copied
Pharmeasy owned Thyrocare Technologies declared an interim dividend of ₹18 per share
11 April 2023
Pharmeasy-owned (66.1% stake)Thyrocare Technologies declared an interim dividend of ₹18 per share for financial 2022-23. The dividend yield comes to around 3.72% based on the current share price of Thyrocare Technologies.